Target Group, Inc. (Canada) (CBDY)
0.0007
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Target Group Cash from Operations (TTM) : -1.073M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.073M |
| March 31, 2026 | -0.3661M |
| December 31, 2025 | -0.8424M |
| September 30, 2025 | 0.1448M |
| June 30, 2025 | 0.3216M |
| March 31, 2025 | 0.8182M |
| December 31, 2024 | 2.163M |
| September 30, 2024 | 1.716M |
| June 30, 2024 | 1.475M |
| March 31, 2024 | 0.3716M |
| December 31, 2023 | -0.5896M |
| September 30, 2023 | -0.8239M |
| June 30, 2023 | -0.1245M |
| March 31, 2023 | -1.350M |
| December 31, 2022 | -1.015M |
| September 30, 2022 | -0.4623M |
| June 30, 2022 | -0.8275M |
| March 31, 2022 | 0.1535M |
| December 31, 2021 | 0.1001M |
| September 30, 2021 | -0.7212M |
| June 30, 2021 | -0.77M |
| March 31, 2021 | -0.4685M |
| December 31, 2020 | -1.433M |
| September 30, 2020 | -1.304M |
| Date | Value |
|---|---|
| June 30, 2020 | -3.528M |
| March 31, 2020 | -5.267M |
| December 31, 2019 | -5.515M |
| September 30, 2019 | -5.242M |
| June 30, 2019 | -3.511M |
| March 31, 2019 | -1.762M |
| December 31, 2018 | -0.6995M |
| September 30, 2018 | -0.9454M |
| June 30, 2018 | -0.2288M |
| March 31, 2018 | -0.2462M |
| December 31, 2017 | -0.2621M |
| September 30, 2017 | -0.2134M |
| June 30, 2017 | -0.3106M |
| March 31, 2017 | -0.3815M |
| December 31, 2016 | -0.421M |
| September 30, 2016 | -0.4649M |
| June 30, 2016 | -0.3354M |
| March 31, 2016 | -0.2352M |
| December 31, 2015 | -0.1799M |
| September 30, 2015 | -0.1348M |
| June 30, 2015 | -0.1078M |
| March 31, 2015 | -0.0642M |
| December 31, 2014 | -0.0091M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Lexaria Bioscience Corp. | -7.426M |
| InMed Pharmaceuticals, Inc. | -8.628M |
| XORTX Therapeutics, Inc. | -5.062M |
| NervGen Pharma Corp. | -18.43M |
| Milestone Pharmaceuticals, Inc. | -60.75M |